Literature DB >> 35430663

ASO Author Reflections: Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery-What We Know and Future Perspectives.

Virginia Vargiu1, Francesco Santullo2, Andrea Rosati3, Barbara Costantini3, Valerio Gallotta3, Claudio Lodoli2, Fabio Pacelli2,4, Giovanni Scambia5,6, Anna Fagotti3,4.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35430663     DOI： 10.1245/s10434-022-11690-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery.

Authors:  Christoph Grimm; Philipp Harter; Pier F Alesina; Sonia Prader; Stephanie Schneider; Beyhan Ataseven; Beate Meier; Violetta Brunkhorst; Jakob Hinrichs; Christian Kurzeder; Florian Heitz; Annett Kahl; Alexander Traut; Harald T Groeben; Martin Walz; Andreas du Bois
Journal:  Gynecol Oncol       Date:  2017-06-10       Impact factor: 5.482

2.  PROFAST: A randomised trial implementing enhanced recovery after surgery for highcomplexity advanced ovarian cancer surgery.

Authors:  José Luis Sánchez-Iglesias; Melchor Carbonell-Socias; Ma Assumpció Pérez-Benavente; Sonia Monreal Clua; Susana Manrique-Muñoz; Manel García Gorriz; Rosa Burgos-Peláez; Hegoi Segurola Gurrutxaga; Mónica Pamies Serrano; Ma Del Pilar Gutiérrez-Barceló; Susana Serrano-Castro; Ma Teresa Balcells-Farré; Carmen Pérez-Barragán; Axelle Scaillet-Houberechts; Yolima Cossio-Gil; Antonio Gil-Moreno
Journal:  Eur J Cancer       Date:  2020-07-18       Impact factor: 9.162

3.  Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer Surgery.

Authors:  A Rosati; V Vargiu; F Santullo; C Lodoli; M Attalla El Halabieh; G Scambia; A Fagotti; B Costantini
Journal:  Ann Surg Oncol       Date:  2021-02-14       Impact factor: 5.344

4.  The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.

Authors:  Dennis S Chi; Oliver Zivanovic; Kimberly L Levinson; Valentin Kolev; Jae Huh; Joseph Dottino; Ginger J Gardner; Mario M Leitao; Douglas A Levine; Yukio Sonoda; Nadeem R Abu-Rustum; Carol L Brown; Richard R Barakat
Journal:  Gynecol Oncol       Date:  2010-07-06       Impact factor: 5.482
  4 in total
  1 in total

1.  Postoperative paralytic ileus following debulking surgery in ovarian cancer patients.

Authors:  Eva K Egger; Freya Merker; Damian J Ralser; Milka Marinova; Tim O Vilz; Hanno Matthaei; Tobias Hilbert; Alexander Mustea
Journal:  Front Surg       Date:  2022-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.